Ayala Pharmaceuticals Inc (fka ADXS)

[raja48185]

Sad part is the company went from being ahead in the game to laggards, even as they raised capital and nothing much has happened - at least till now and seems to be so for the rest of 2017, based on the company's own outlook for 2017.

Misplaced priorities, trying to do too much at a time - as if this were a BP, and who knows what missteps management has taken over these years, have affected the stock price, the confidence of investors and the health of the company.

This is no longer a baby biotech in terms of years in being in business. More like a old dog that has lost its teeth and some bite.